A detailed history of Allspring Global Investments Holdings, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Allspring Global Investments Holdings, LLC holds 6,660 shares of BIIB stock, worth $1.16 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
6,660
Previous 7,519 11.42%
Holding current value
$1.16 Million
Previous $1.74 Million 25.99%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$189.07 - $236.8 $162,411 - $203,411
-859 Reduced 11.42%
6,660 $1.29 Million
Q2 2024

Jul 26, 2024

SELL
$190.52 - $236.72 $39,056 - $48,527
-205 Reduced 2.65%
7,519 $1.74 Million
Q1 2024

Apr 18, 2024

SELL
$212.02 - $267.71 $3.5 Million - $4.42 Million
-16,514 Reduced 68.13%
7,724 $1.67 Million
Q4 2023

Jan 25, 2024

SELL
$222.59 - $267.94 $7.5 Million - $9.02 Million
-33,675 Reduced 58.15%
24,238 $6.27 Million
Q3 2023

Oct 27, 2023

BUY
$253.3 - $285.89 $14.7 Million - $16.6 Million
57,913 New
57,913 $14.9 Million
Q2 2023

Jul 18, 2023

SELL
$275.25 - $318.06 $2.43 Million - $2.81 Million
-8,833 Reduced 12.96%
59,336 $16.9 Million
Q1 2023

Apr 13, 2023

SELL
$256.56 - $292.34 $8.34 Million - $9.5 Million
-32,497 Reduced 32.28%
68,169 $19 Million
Q4 2022

Jan 23, 2023

BUY
$252.44 - $306.72 $5.86 Million - $7.12 Million
23,212 Added 29.97%
100,666 $0
Q3 2022

Oct 26, 2022

SELL
$194.69 - $268.46 $952,618 - $1.31 Million
-4,893 Reduced 5.94%
77,454 $20.7 Million
Q2 2022

Jul 25, 2022

BUY
$187.54 - $223.02 $8.4 Million - $9.99 Million
44,799 Added 119.31%
82,347 $16.8 Million
Q1 2022

May 02, 2022

SELL
$193.77 - $244.14 $1.11 Million - $1.4 Million
-5,714 Reduced 13.21%
37,548 $7.91 Million
Q4 2021

Jan 28, 2022

BUY
$223.92 - $287.77 $9.69 Million - $12.4 Million
43,262 New
43,262 $10.4 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Allspring Global Investments Holdings, LLC Portfolio

Follow Allspring Global Investments Holdings, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Allspring Global Investments Holdings, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Allspring Global Investments Holdings, LLC with notifications on news.